Search results
Added:
3 years ago
Drug-coated balloons (DCBs) are a nascent technology gaining a lot of attention among cardiologists and angiologists worldwide. As opposed to drug-eluting stents (DES) they allow intraluminal drug application to diseased arterial tissue without leaving an implant such as a metal scaffold behind. This may be beneficial where a stent is already in place or where stenting is problematic due to…
View more
Added:
3 years ago
Cardiovascular Disease
Cardiovascular disease associated with atherosclerosis is a condition mainly associated with a thickening of the artery wall and the eventual blockage of blood flow in an artery due to fatty deposits and plaque formation. When cardiovascular disease is brought to mind, the heart is what people think of most; however, although the heart is the predominant organ affected by…
View more
Added:
6 months ago
What's hot at TCT 2023?
In this episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the late-breaking data presented at TCT 2023.
With their dynamic analysis, these anticipated trials are placed in context, highlighting the real-world implications tied to the data releases.
Top trials covered:
00:31 - 02:12: PARTNER 3 Low…
View more
Added:
3 years ago
When Andreas Grüntzig introduced balloon coronary angioplasty in 1977 it represented the first alternative to coronary artery bypass graft surgery. However, balloon dilatation had inherent limitations – including elastic recoil and vessel closure in the acute phase, as well as negative remodelling and restenosis in the late phase – which limited its applicability and further expansion. In the…
View more
Added:
5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice.
Trials covered in detail include:
Agent IDE
ALIGN-AR
PARTNER 3
EVOLUT Low-Risk
TRISCEND
Recorded remotely from Jeddah, 2023.
Editor: Jordan Rance
Video Specialist:…
View more
Added:
3 years ago
Stent thrombosis (ST) is the sudden occlusion of a stented coronary artery due to thrombus formation. The clinical consequences of ST are frequently catastrophic – most episodes occur within two weeks of stent implantation – and include death in 20–48% or major myocardial infarction (MI) in 60–70% of cases.1–3 When bare-metal stents (BMS) were first introduced, ST was a common complication…
View more
Added:
3 years ago
“I do not know what I may appear to the world, but to myself I seem to have been only like a boy playing on the sea-shore, diverting myself in now and then finding a smoother pebble or a prettier shell than ordinary, whilst the great ocean of truth lay all undiscovered before me.” Sir Isaac Newton
Advances in Percutaneous Coronary Intervention – An Overview
Over the last 10 years, the…
View more
TCT 23: AGENT IDE
Added:
5 months ago
Video
Added:
5 years ago
Prof Marianne Brodmann (Medical University of Graz, AT) discusses safety of pacilitaxel coated balloons.
Filmed on site by Radcliffe Cardiology.
Questions:
1.There have been safety concerns with paclitaxel DCB's. What is your take on this? (00:09)
2.Are you still implanting drug coated balloons? (02:16)
View more
Added:
1 year ago
Dr Bernardo Cortese (La Fondazione Ricerca e Innovazione Cardiovascolare, IT) discusses the findings from the EASTBOURNE Registry, a study that investigated the sirolimus-coated balloon in an all-comer population.
Findings are positive in regard to the device's safety and efficacy profile, with no safety signals for bleeding and the primary endpoint of target lesion revascularization (TLR), was…
View more
